51282
Deoxyfuconojirimycin hydrochloride
≥98.0% (TLC)
Synonym(s):
1,5-Dideoxy-1,5-imino-L-fucitol hydrochloride
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C6H13NO3 · HCl
CAS Number:
Molecular Weight:
183.63
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12352201
MDL number:
InChI key
SHSBWMUIVLOMIL-NQZVPSPJSA-N
SMILES string
Cl.C[C@@H]1NC[C@@H](O)[C@H](O)[C@@H]1O
InChI
1S/C6H13NO3.ClH/c1-3-5(9)6(10)4(8)2-7-3;/h3-10H,2H2,1H3;1H/t3-,4+,5+,6-;/m0./s1
assay
≥98.0% (TLC)
Biochem/physiol Actions
Deoxyfuconojirimycin is a specific and competitive inhibitor of human liver α-L-fucosidase.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Other Notes
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression.
Kun Yuan et al.
Pathology oncology research : POR, 14(2), 145-156 (2008-06-17)
Glycosylation drives critical processes important for mammalian cell-cell and cell-matrix interactions. Alpha-L-fucose (alpha-L-f) is a key monosaccharide component of oligosaccharides that has been found to be overexpressed during tumor progression. Modification of cell surface fucosylation, we hypothesized, alters tumor cell
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service